Skip to content

Clinical trials

Thrombocytopenia trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Country / region: South Korea Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20091
20101
20113
20132
20143
20211
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Terminated3
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
GlaxoSmithKline3
Takeda2
Bristol-Myers Squibb1
Cooperative Study Group A for Hematology1
Eisai Inc.1
Karyopharm Therapeutics Inc1
Kyowa Kirin Korea Co., Ltd.1
Ono Pharma USA Inc1
South Eastern Sydney Local Health District1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia17
Myelodysplastic Syndromes5
Purpura, Thrombocytopenic, Idiopathic4
Leukemia, Myeloid, Acute3
Anemia2
Primary Myelofibrosis2
Purpura2
Acquired Immunodeficiency Syndrome1
Anemia, Aplastic1
Autoimmune Diseases1

Trials

Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.